Navigation Links
Alzheimer's drug developer lands $1.2M in venture funding

Madison, Wis. - Mithridion, Inc., a biopharmaceutical start up that is developing drugs to disrupt the progress of Alzheimer's disease, has closed an additional $1.2 million of Series A funding led by Madison's Venture Investors.

The latest round of funding brings the total equity capital raised in th......

Full article >>> s, and the continued support of WARF and Rosetta Partners.

"It's a great leap forward for our company in getting Venture Investors, a professional investment firm," Twose said. "It's not only a leap forward in terms of getting the funding, it's the quality of the investors they bring in."

The new funding will be used to advance Mithridion's drug lead, a prototype drug that will b......

Full article >>> ts discovery is based on animal models used in Alzheimer's research. "It was noted that they [the animals] did not develop the full form of Alzheimer's, which caused investors to ask why?" Neis said.


Full article >>>
'"/> By WTN News 04/17/07

Related biology technology :

1. Biotech firm has strokes, Alzheimers in its sights
2. Mithridion wins grants for Alzheimers research
3. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
4. Alzheimers drug market to hit $5.5 billion by 2009, study says
5. Marshfield study mixes DNA into electronic medical record to screen for Alzheimers
6. UW Alzheimers researchers found company; privacy law; Science Expeditions
7. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
8. Discovery may halt progression of Alzheimers
9. Milwaukee software developer gains bottom line, loses waistline
10. Emerging game developer begins work on prototypes
11. Metavante to buy California software developer
Post Your Comments:

(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, former ... of the University of North Carolina Kenan-Flagler Business School effective June ... UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes and ...
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
Breaking Biology Technology:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):